Clinical Trial

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Name: A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus — clinical trial record (NCT07323173)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Phase I, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Study of Single Subcutaneous Injections of LBL-047 in Healthy Adults and Patients with systemic lupus erythematosus.

Protocol Amendment History 1 change

notable Trial sites expanded: 1 -> 11 locations 2026-04-15

Trial Details

NCT Number	NCT07323173
Lead Sponsor	Nanjing Leads Biolabs Co.,Ltd Collaborators: Shanghai Public Health Clinical Center, RenJi Hospital
Conditions	Systemic Lupus Erythematosus
Enrollment	112 participants
Start Date	2025-12-16
Primary Completion	2027-12-16 (estimated)
Study Completion	2027-12-16 (estimated)
Updated on ClinicalTrials.gov	2026-04-14